Pulmonary Pharmacology & Therapeutics

译名:肺部药理学与治疗学

PULMONARY PHARMACOLOGY & THERAPEUTICS

SCIEJCR Q2

3-5

2026

影响因子区间

163天

平台估算

投稿周期

26%

2025

中国作者发文占比

40000000 IRR;600 USD

费用说明

收费

期刊简介:Pulmonary Pharmacology and Therapeutics (formerly Pulmonary Pharmacology) is concerned with lung pharmacology from molecular to clinical aspects. The subject matter encompasses the major diseases of the lung including asthma, cystic fibrosis, pulmonary circulation, ARDS, carcinoma, bronchitis, emphysema and drug delivery. Laboratory and clinical research on man and animals will be considered including studies related to chemotherapy of cancer, tuberculosis and infection. In addition to original research papers the journal will include review articles and book reviews.Research Areas Include:• All major diseases of the lung• Physiology• Pathology• Drug delivery• Metabolism• Pulmonary Toxicology.

【译文】肺药理学和治疗学(原名肺药理学)关注从分子到临床方面的肺药理学。主题包括肺的主要疾病,如哮喘、囊性纤维化、肺循环、急性呼吸窘迫综合征、癌症、支气管炎、肺气肿和药物递送。包括人类和动物实验室和临床研究,包括与癌症化疗、结核和感染相关的研究。除了原创研究论文,该期刊还将包括综述文章和书评。研究领域包括:• 肺的所有主要疾病• 生理学• 病理学• 药物递送• 代谢• 肺毒理学。

出版社
Elsevier BV
语言
English
学科
医学
ISSN
1094-5539
eISSN
1522-9629
出版频率
双月刊
创刊年份
1997
投稿网址
https://www.editorialmanager.com/YPUPT
最近更新
2026-04-02 18:16:40
Pulmonary Pharmacology & Therapeutics

指标当前值近三年趋势
JCR分区Q2
暂无
影响因子区间3-5
暂无